303 related articles for article (PubMed ID: 17125260)
21. ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors.
Kumari R; Goh G; Ng LL; Boarder MR
Br J Pharmacol; 2003 Dec; 140(7):1169-76. PubMed ID: 14597595
[TBL] [Abstract][Full Text] [Related]
22. Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction.
Wihlborg AK; Balogh J; Wang L; Borna C; Dou Y; Joshi BV; Lazarowski E; Jacobson KA; Arner A; Erlinge D
Circ Res; 2006 Apr; 98(7):970-6. PubMed ID: 16543499
[TBL] [Abstract][Full Text] [Related]
23. Molecular pharmacology of P2Y-receptors.
von Kügelgen I; Wetter A
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
[TBL] [Abstract][Full Text] [Related]
24. 4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.
Jayasekara PS; Barrett MO; Ball CB; Brown KA; Hammes E; Balasubramanian R; Harden TK; Jacobson KA
J Med Chem; 2014 May; 57(9):3874-83. PubMed ID: 24712832
[TBL] [Abstract][Full Text] [Related]
25. UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor.
Lazarowski ER; Paradiso AM; Watt WC; Harden TK; Boucher RC
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2599-603. PubMed ID: 9122241
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.
Cosyn L; Van Calenbergh S; Joshi BV; Ko H; Carter RL; Kendall Harden T; Jacobson KA
Bioorg Med Chem Lett; 2009 Jun; 19(11):3002-5. PubMed ID: 19419868
[TBL] [Abstract][Full Text] [Related]
27. Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.
Guns PJ; Van Assche T; Fransen P; Robaye B; Boeynaems JM; Bult H
Br J Pharmacol; 2006 Mar; 147(5):569-74. PubMed ID: 16415908
[TBL] [Abstract][Full Text] [Related]
28. Distribution of P2Y receptor subtypes on haematopoietic cells.
Jin J; Dasari VR; Sistare FD; Kunapuli SP
Br J Pharmacol; 1998 Mar; 123(5):789-94. PubMed ID: 9535005
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists.
Meltzer D; Ethan O; Arguin G; Nadel Y; Danino O; Lecka J; Sévigny J; Gendron FP; Fischer B
Bioorg Med Chem; 2015 Sep; 23(17):5764-73. PubMed ID: 26233801
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
Pendergast W; Yerxa BR; Douglass JG; Shaver SR; Dougherty RW; Redick CC; Sims IF; Rideout JL
Bioorg Med Chem Lett; 2001 Jan; 11(2):157-60. PubMed ID: 11206448
[TBL] [Abstract][Full Text] [Related]
31. Mechanically evoked reflex electrogenic chloride secretion in rat distal colon is triggered by endogenous nucleotides acting at P2Y1, P2Y2, and P2Y4 receptors.
Christofi FL; Wunderlich J; Yu JG; Wang YZ; Xue J; Guzman J; Javed N; Cooke H
J Comp Neurol; 2004 Jan; 469(1):16-36. PubMed ID: 14689471
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists.
Dales MO; Mitchell C; Gurney AM; Drummond RM; Kennedy C
Purinergic Signal; 2022 Dec; 18(4):515-528. PubMed ID: 36018534
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of the human P2Y4 receptor.
Communi D; Motte S; Boeynaems JM; Pirotton S
Eur J Pharmacol; 1996 Dec; 317(2-3):383-9. PubMed ID: 8997625
[TBL] [Abstract][Full Text] [Related]
34. New insights on pyrimidine signalling within the arterial vasculature - Different roles for P2Y2 and P2Y6 receptors in large and small coronary arteries of the mouse.
Haanes KA; Spray S; Syberg S; Jørgensen NR; Robaye B; Boeynaems JM; Edvinsson L
J Mol Cell Cardiol; 2016 Apr; 93():1-11. PubMed ID: 26827897
[TBL] [Abstract][Full Text] [Related]
35. Differential agonist-induced desensitization of P2Y2 nucleotide receptors by ATP and UTP.
Velázquez B; Garrad RC; Weisman GA; González FA
Mol Cell Biochem; 2000 Mar; 206(1-2):75-89. PubMed ID: 10839197
[TBL] [Abstract][Full Text] [Related]
36. Desensitization of P2Y2 receptor-activated transepithelial anion secretion.
Clarke LL; Harline MC; Otero MA; Glover GG; Garrad RC; Krugh B; Walker NM; González FA; Turner JT; Weisman GA
Am J Physiol; 1999 Apr; 276(4):C777-87. PubMed ID: 10199807
[TBL] [Abstract][Full Text] [Related]
37. Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6.
Roberts VH; Greenwood SL; Elliott AC; Sibley CP; Waters LH
Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1374-86. PubMed ID: 16373435
[TBL] [Abstract][Full Text] [Related]
38. Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179.
Kaiser RA; Buxton IL
Br J Pharmacol; 2002 Jan; 135(2):537-45. PubMed ID: 11815389
[TBL] [Abstract][Full Text] [Related]
39. Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP.
Harper S; Webb TE; Charlton SJ; Ng LL; Boarder MR
Br J Pharmacol; 1998 Jun; 124(4):703-10. PubMed ID: 9690862
[TBL] [Abstract][Full Text] [Related]
40. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
Schachter JB; Harden TK
Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
